Industry Research Reports
Home > Reports > Chemical & Material > Global Amikacin Sulfate Market Outlook, In‑Depth Analysis & Forecast to 2031
Global Amikacin Sulfate Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Chemical & Material
Published Date: 2025-10-25
Pages: 137 Pages
Report ld: 5264227
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global Amikacin Sulfate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
From a downstream perspective, Amikacin Sulfate Injection accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Amikacin Sulfate leading manufacturers including Chengdu Brilliant Pharmaceutical Group, Chongqing Daxin Pharmaceutical, Interquim Mexico, CONBA Group, Suanfarma, HangZhou HuiSheng Biotech Pharmaceutical, Iffect Chemphar, Triveni Interchem, NC Pharm, Qilu Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Chengdu Brilliant Pharmaceutical Group leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips business leaders, decision-makers and stakeholders with a 360° view of the global Amikacin Sulfate market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Chengdu Brilliant Pharmaceutical Group
- Chongqing Daxin Pharmaceutical
- Interquim Mexico
- CONBA Group
- Suanfarma
- HangZhou HuiSheng Biotech Pharmaceutical
- Iffect Chemphar
- Triveni Interchem
- NC Pharm
- Qilu Pharmaceutical
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Purity≥98%
- Purity≥99%
Segment by Application
- Amikacin Sulfate Injection
- Other
CHAPTER OUTLINE
Chapter 1: Defines the Amikacin Sulfate study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; top manufactures 2024 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Amikacin Sulfate: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Amikacin Sulfate Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Purity≥98%
1.2.3 Purity≥99%
1.3 Market Segmentation by Application
1.3.1 Global Amikacin Sulfate Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Amikacin Sulfate Injection
1.3.3 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Amikacin Sulfate Revenue Estimates and Forecasts 2020-2031
2.2 Global Amikacin Sulfate Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Amikacin Sulfate Sales Estimates and Forecasts 2020-2031
2.4 Global Amikacin Sulfate Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Amikacin Sulfate Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Amikacin Sulfate Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Amikacin Sulfate Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 Purity≥98% Market Size by Manufacturers
4.5.2 Purity≥99% Market Size by Manufacturers
4.6 Global Amikacin Sulfate Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Amikacin Sulfate Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Amikacin Sulfate Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Amikacin Sulfate Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Amikacin Sulfate Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Amikacin Sulfate Sales and Revenue by Type (2020-2031)
7.4 North America Amikacin Sulfate Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Amikacin Sulfate Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Amikacin Sulfate Sales and Revenue by Type (2020-2031)
8.4 Europe Amikacin Sulfate Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Amikacin Sulfate Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Amikacin Sulfate Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Amikacin Sulfate Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Amikacin Sulfate Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Amikacin Sulfate Sales and Revenue by Type (2020-2031)
10.4 Central and South America Amikacin Sulfate Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Amikacin Sulfate Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Amikacin Sulfate Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Amikacin Sulfate Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Amikacin Sulfate Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Chengdu Brilliant Pharmaceutical Group
12.1.1 Chengdu Brilliant Pharmaceutical Group Corporation Information
12.1.2 Chengdu Brilliant Pharmaceutical Group Business Overview
12.1.3 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Product Models, Descriptions and Specifications
12.1.4 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Sales by Product in 2024
12.1.6 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Sales by Application in 2024
12.1.7 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate Sales by Geographic Area in 2024
12.1.8 Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate SWOT Analysis
12.1.9 Chengdu Brilliant Pharmaceutical Group Recent Developments
12.2 Chongqing Daxin Pharmaceutical
12.2.1 Chongqing Daxin Pharmaceutical Corporation Information
12.2.2 Chongqing Daxin Pharmaceutical Business Overview
12.2.3 Chongqing Daxin Pharmaceutical Amikacin Sulfate Product Models, Descriptions and Specifications
12.2.4 Chongqing Daxin Pharmaceutical Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Chongqing Daxin Pharmaceutical Amikacin Sulfate Sales by Product in 2024
12.2.6 Chongqing Daxin Pharmaceutical Amikacin Sulfate Sales by Application in 2024
12.2.7 Chongqing Daxin Pharmaceutical Amikacin Sulfate Sales by Geographic Area in 2024
12.2.8 Chongqing Daxin Pharmaceutical Amikacin Sulfate SWOT Analysis
12.2.9 Chongqing Daxin Pharmaceutical Recent Developments
12.3 Interquim Mexico
12.3.1 Interquim Mexico Corporation Information
12.3.2 Interquim Mexico Business Overview
12.3.3 Interquim Mexico Amikacin Sulfate Product Models, Descriptions and Specifications
12.3.4 Interquim Mexico Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Interquim Mexico Amikacin Sulfate Sales by Product in 2024
12.3.6 Interquim Mexico Amikacin Sulfate Sales by Application in 2024
12.3.7 Interquim Mexico Amikacin Sulfate Sales by Geographic Area in 2024
12.3.8 Interquim Mexico Amikacin Sulfate SWOT Analysis
12.3.9 Interquim Mexico Recent Developments
12.4 CONBA Group
12.4.1 CONBA Group Corporation Information
12.4.2 CONBA Group Business Overview
12.4.3 CONBA Group Amikacin Sulfate Product Models, Descriptions and Specifications
12.4.4 CONBA Group Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 CONBA Group Amikacin Sulfate Sales by Product in 2024
12.4.6 CONBA Group Amikacin Sulfate Sales by Application in 2024
12.4.7 CONBA Group Amikacin Sulfate Sales by Geographic Area in 2024
12.4.8 CONBA Group Amikacin Sulfate SWOT Analysis
12.4.9 CONBA Group Recent Developments
12.5 Suanfarma
12.5.1 Suanfarma Corporation Information
12.5.2 Suanfarma Business Overview
12.5.3 Suanfarma Amikacin Sulfate Product Models, Descriptions and Specifications
12.5.4 Suanfarma Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Suanfarma Amikacin Sulfate Sales by Product in 2024
12.5.6 Suanfarma Amikacin Sulfate Sales by Application in 2024
12.5.7 Suanfarma Amikacin Sulfate Sales by Geographic Area in 2024
12.5.8 Suanfarma Amikacin Sulfate SWOT Analysis
12.5.9 Suanfarma Recent Developments
12.6 HangZhou HuiSheng Biotech Pharmaceutical
12.6.1 HangZhou HuiSheng Biotech Pharmaceutical Corporation Information
12.6.2 HangZhou HuiSheng Biotech Pharmaceutical Business Overview
12.6.3 HangZhou HuiSheng Biotech Pharmaceutical Amikacin Sulfate Product Models, Descriptions and Specifications
12.6.4 HangZhou HuiSheng Biotech Pharmaceutical Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 HangZhou HuiSheng Biotech Pharmaceutical Recent Developments
12.7 Iffect Chemphar
12.7.1 Iffect Chemphar Corporation Information
12.7.2 Iffect Chemphar Business Overview
12.7.3 Iffect Chemphar Amikacin Sulfate Product Models, Descriptions and Specifications
12.7.4 Iffect Chemphar Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 Iffect Chemphar Recent Developments
12.8 Triveni Interchem
12.8.1 Triveni Interchem Corporation Information
12.8.2 Triveni Interchem Business Overview
12.8.3 Triveni Interchem Amikacin Sulfate Product Models, Descriptions and Specifications
12.8.4 Triveni Interchem Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 Triveni Interchem Recent Developments
12.9 NC Pharm
12.9.1 NC Pharm Corporation Information
12.9.2 NC Pharm Business Overview
12.9.3 NC Pharm Amikacin Sulfate Product Models, Descriptions and Specifications
12.9.4 NC Pharm Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 NC Pharm Recent Developments
12.10 Qilu Pharmaceutical
12.10.1 Qilu Pharmaceutical Corporation Information
12.10.2 Qilu Pharmaceutical Business Overview
12.10.3 Qilu Pharmaceutical Amikacin Sulfate Product Models, Descriptions and Specifications
12.10.4 Qilu Pharmaceutical Amikacin Sulfate Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Qilu Pharmaceutical Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Amikacin Sulfate Industry Chain
13.2 Amikacin Sulfate Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Amikacin Sulfate Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Amikacin Sulfate Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Amikacin Sulfate Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Amikacin Sulfate Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global Amikacin Sulfate Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Amikacin Sulfate Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Amikacin Sulfate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Amikacin Sulfate Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Amikacin Sulfate Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global Amikacin Sulfate Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 7. Global Amikacin Sulfate Sales by Region (2020-2025) & (MT)
Table 8. Global Amikacin Sulfate Sales by Region (2026-2031) & (MT)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global Amikacin Sulfate Production Growth Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (MT)
Table 11. Global Amikacin Sulfate Production by Region (2020-2025) & (MT)
Table 12. Global Amikacin Sulfate Production by Region (2026-2031) & (MT)
Table 13. Global Amikacin Sulfate Sales by Manufacturers (2020-2025) & (MT)
Table 14. Global Amikacin Sulfate Sales Share by Manufacturers (2020-2025)
Table 15. Global Amikacin Sulfate Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 16. Global Amikacin Sulfate Revenue Market Share by Manufacturers (2020-2025)
Table 17. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 18. Global Amikacin Sulfate by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amikacin Sulfate as of 2024)
Table 19. Global Amikacin Sulfate Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 20. Global Amikacin Sulfate Average Selling Price (ASP) by Manufacturers (2020-2025) & (USD/Kg)
Table 21. Key Manufacturers Amikacin Sulfate Manufacturing Base and Headquarters
Table 22. Global Amikacin Sulfate Market Concentration Ratio (CR5 and HHI)
Table 23. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Amikacin Sulfate Sales by Type (2020-2025) & (MT)
Table 26. Global Amikacin Sulfate Sales by Type (2026-2031) & (MT)
Table 27. Global Amikacin Sulfate Revenue by Type (2020-2025) & (US$ Million)
Table 28. Global Amikacin Sulfate Revenue by Type (2026-2031) & (US$ Million)
Table 29. Global Amikacin Sulfate ASP by Type (2020-2031) & (USD/Kg)
Table 30. Technical Specifications by Key Product Type
Table 31. Global Amikacin Sulfate Sales by Application (2020-2025) & (MT)
Table 32. Global Amikacin Sulfate Sales by Application (2026-2031) & (MT)
Table 33. Amikacin Sulfate High-Growth Sectors Demand CAGR (2024-2031)
Table 34. Global Amikacin Sulfate Revenue by Application (2020-2025) & (US$ Million)
Table 35. Global Amikacin Sulfate Revenue by Application (2026-2031) & (US$ Million)
Table 36. Global Amikacin Sulfate ASP by Application (2020-2031) & (USD/Kg)
Table 37. Top Customers by Region
Table 38. Top Customers by Application
Table 39. North America Amikacin Sulfate Growth Accelerators and Market Barriers
Table 40. North America Amikacin Sulfate Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 41. North America Amikacin Sulfate Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 42. Europe Amikacin Sulfate Growth Accelerators and Market Barriers
Table 43. Europe Amikacin Sulfate Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 44. Europe Amikacin Sulfate Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 45. Asia-Pacific Amikacin Sulfate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Asia-Pacific Amikacin Sulfate Sales (MT) by Country (2020 VS 2024 VS 2031)
Table 47. Asia-Pacific Amikacin Sulfate Growth Accelerators and Market Barriers
Table 48. Southeast Asia Amikacin Sulfate Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 49. Central and South America Amikacin Sulfate Investment Opportunities and Key Challenges
Table 50. Central and South America Amikacin Sulfate Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 51. Middle East and Africa Amikacin Sulfate Investment Opportunities and Key Challenges
Table 52. Middle East and Africa Amikacin Sulfate Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 53. Chengdu Brilliant Pharmaceutical Group Corporation Information
Table 54. Chengdu Brilliant Pharmaceutical Group Description and Major Businesses
Table 55. Chengdu Brilliant Pharmaceutical Group Product Models, Descriptions and Specifications
Table 56. Chengdu Brilliant Pharmaceutical Group Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 57. Chengdu Brilliant Pharmaceutical Group Sales Value Proportion by Product in 2024
Table 58. Chengdu Brilliant Pharmaceutical Group Sales Value Proportion by Application in 2024
Table 59. Chengdu Brilliant Pharmaceutical Group Sales Value Proportion by Geographic Area in 2024
Table 60. Chengdu Brilliant Pharmaceutical Group Amikacin Sulfate SWOT Analysis
Table 61. Chengdu Brilliant Pharmaceutical Group Recent Developments
Table 62. Chongqing Daxin Pharmaceutical Corporation Information
Table 63. Chongqing Daxin Pharmaceutical Description and Major Businesses
Table 64. Chongqing Daxin Pharmaceutical Product Models, Descriptions and Specifications
Table 65. Chongqing Daxin Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 66. Chongqing Daxin Pharmaceutical Sales Value Proportion by Product in 2024
Table 67. Chongqing Daxin Pharmaceutical Sales Value Proportion by Application in 2024
Table 68. Chongqing Daxin Pharmaceutical Sales Value Proportion by Geographic Area in 2024
Table 69. Chongqing Daxin Pharmaceutical Amikacin Sulfate SWOT Analysis
Table 70. Chongqing Daxin Pharmaceutical Recent Developments
Table 71. Interquim Mexico Corporation Information
Table 72. Interquim Mexico Description and Major Businesses
Table 73. Interquim Mexico Product Models, Descriptions and Specifications
Table 74. Interquim Mexico Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 75. Interquim Mexico Sales Value Proportion by Product in 2024
Table 76. Interquim Mexico Sales Value Proportion by Application in 2024
Table 77. Interquim Mexico Sales Value Proportion by Geographic Area in 2024
Table 78. Interquim Mexico Amikacin Sulfate SWOT Analysis
Table 79. Interquim Mexico Recent Developments
Table 80. CONBA Group Corporation Information
Table 81. CONBA Group Description and Major Businesses
Table 82. CONBA Group Product Models, Descriptions and Specifications
Table 83. CONBA Group Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 84. CONBA Group Sales Value Proportion by Product in 2024
Table 85. CONBA Group Sales Value Proportion by Application in 2024
Table 86. CONBA Group Sales Value Proportion by Geographic Area in 2024
Table 87. CONBA Group Amikacin Sulfate SWOT Analysis
Table 88. CONBA Group Recent Developments
Table 89. Suanfarma Corporation Information
Table 90. Suanfarma Description and Major Businesses
Table 91. Suanfarma Product Models, Descriptions and Specifications
Table 92. Suanfarma Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 93. Suanfarma Sales Value Proportion by Product in 2024
Table 94. Suanfarma Sales Value Proportion by Application in 2024
Table 95. Suanfarma Sales Value Proportion by Geographic Area in 2024
Table 96. Suanfarma Amikacin Sulfate SWOT Analysis
Table 97. Suanfarma Recent Developments
Table 98. HangZhou HuiSheng Biotech Pharmaceutical Corporation Information
Table 99. HangZhou HuiSheng Biotech Pharmaceutical Description and Major Businesses
Table 100. HangZhou HuiSheng Biotech Pharmaceutical Product Models, Descriptions and Specifications
Table 101. HangZhou HuiSheng Biotech Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 102. HangZhou HuiSheng Biotech Pharmaceutical Recent Developments
Table 103. Iffect Chemphar Corporation Information
Table 104. Iffect Chemphar Description and Major Businesses
Table 105. Iffect Chemphar Product Models, Descriptions and Specifications
Table 106. Iffect Chemphar Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 107. Iffect Chemphar Recent Developments
Table 108. Triveni Interchem Corporation Information
Table 109. Triveni Interchem Description and Major Businesses
Table 110. Triveni Interchem Product Models, Descriptions and Specifications
Table 111. Triveni Interchem Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 112. Triveni Interchem Recent Developments
Table 113. NC Pharm Corporation Information
Table 114. NC Pharm Description and Major Businesses
Table 115. NC Pharm Product Models, Descriptions and Specifications
Table 116. NC Pharm Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 117. NC Pharm Recent Developments
Table 118. Qilu Pharmaceutical Corporation Information
Table 119. Qilu Pharmaceutical Description and Major Businesses
Table 120. Qilu Pharmaceutical Product Models, Descriptions and Specifications
Table 121. Qilu Pharmaceutical Capacity, Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2020-2025)
Table 122. Qilu Pharmaceutical Recent Developments
Table 123. Key Raw Materials Distribution
Table 124. Raw Materials Key Suppliers
Table 125. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 126. Milestones in Production Technology Evolution
Table 127. Distributors List
Table 128. Market Trends and Market Evolution
Table 129. Market Drivers and Opportunities
Table 130. Market Challenges, Risks, and Restraints
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Amikacin Sulfate Product Picture
Figure 2. Global Amikacin Sulfate Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Purity≥98% Product Picture
Figure 4. Purity≥99% Product Picture
Figure 5. Global Amikacin Sulfate Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Amikacin Sulfate Injection
Figure 7. Other
Figure 8. Amikacin Sulfate Report Years Considered
Figure 9. Global Amikacin Sulfate Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 10. Global Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 11. Global Amikacin Sulfate Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 12. Global Amikacin Sulfate Revenue Market Share by Region (2020-2031)
Figure 13. Global Amikacin Sulfate Sales (2020-2031) & (MT)
Figure 14. Global Amikacin Sulfate Sales (CAGR) by Region (2020-2031) (MT)
Figure 15. Global Amikacin Sulfate Sales Market Share by Region (2020-2031)
Figure 16. Global Amikacin Sulfate Capacity, Production and Utilization (2020-2031) & (MT)
Figure 17. Global Amikacin Sulfate Production Trend by Region (2020-2031) (MT)
Figure 18. Global Amikacin Sulfate Production Market Share by Region (2020-2031)
Figure 19. Production Capacity Enablers & Constraints
Figure 20. Amikacin Sulfate Production Growth Rate in North America (2020-2031) & (MT)
Figure 21. Amikacin Sulfate Production Growth Rate in Europe (2020-2031) & (MT)
Figure 22. Amikacin Sulfate Production Growth Rate in China (2020-2031) & (MT)
Figure 23. Amikacin Sulfate Production Growth Rate in Japan (2020-2031) & (MT)
Figure 24. Top 5 and Top 10 Manufacturers Amikacin Sulfate Sales Volume Market Share in 2024
Figure 25. Global Amikacin Sulfate Revenue Market Share Ranking (2024)
Figure 26. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 27. Purity≥98% Revenue Market Share by Manufacturer in 2024
Figure 28. Purity≥99% Revenue Market Share by Manufacturer in 2024
Figure 29. Type Eight Revenue Market Share by Manufacturer in 2024
Figure 30. Type Nine Revenue Market Share by Manufacturer in 2024
Figure 31. Global Amikacin Sulfate Sales Market Share by Type (2020-2031)
Figure 32. Global Amikacin Sulfate Revenue Market Share by Type (2020-2031)
Figure 33. Global Amikacin Sulfate Sales Market Share by Application (2020-2031)
Figure 34. Global Amikacin Sulfate Revenue Market Share by Application (2020-2031)
Figure 35. North America Amikacin Sulfate Sales YoY (2020-2031) & (MT)
Figure 36. North America Amikacin Sulfate Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers Amikacin Sulfate Sales Revenue (US$ Million) in 2024
Figure 38. North America Amikacin Sulfate Sales Volume (MT) by Type (2020- 2031)
Figure 39. North America Amikacin Sulfate Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America Amikacin Sulfate Sales Volume (MT) by Application (2020-2031)
Figure 41. North America Amikacin Sulfate Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 43. Canada Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 45. Europe Amikacin Sulfate Sales YoY (2020-2031) & (MT)
Figure 46. Europe Amikacin Sulfate Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers Amikacin Sulfate Sales Revenue (US$ Million) in 2024
Figure 48. Europe Amikacin Sulfate Sales Volume (MT) by Type (2020-2031)
Figure 49. Europe Amikacin Sulfate Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe Amikacin Sulfate Sales Volume (MT) by Application (2020-2031)
Figure 51. Europe Amikacin Sulfate Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 53. France Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 55. Italy Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 56. Russia Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific Amikacin Sulfate Sales YoY (2020-2031) & (MT)
Figure 58. Asia-Pacific Amikacin Sulfate Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers Amikacin Sulfate Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific Amikacin Sulfate Sales Volume (MT) by Type (2020- 2031)
Figure 61. Asia-Pacific Amikacin Sulfate Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific Amikacin Sulfate Sales Volume (MT) by Application (2020-2031)
Figure 63. Asia-Pacific Amikacin Sulfate Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 65. Japan Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 68. India Amikacin Sulfate Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America Amikacin Sulfate Sales YoY (2020-2031) & (MT)
Figure 70. Central and South America Amikacin Sulfate Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers Amikacin Sulfate Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America Amikacin Sulfate Sales Volume (MT) by Type (2021-2031)
Figure 73. Central and South America Amikacin Sulfate Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America Amikacin Sulfate Sales Volume (MT) by Application (2020-2031)
Figure 75. Central and South America Amikacin Sulfate Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil Amikacin Sulfate Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina Amikacin Sulfate Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa Amikacin Sulfate Sales YoY (2020-2031) & (MT)
Figure 79. Middle East and Africa Amikacin Sulfate Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers Amikacin Sulfate Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa Amikacin Sulfate Sales Volume (MT) by Type (2021-2031)
Figure 82. South America Amikacin Sulfate Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa Amikacin Sulfate Sales Volume (MT) by Application (2020-2031)
Figure 84. Middle East and Africa Amikacin Sulfate Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries Amikacin Sulfate Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey Amikacin Sulfate Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt Amikacin Sulfate Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa Amikacin Sulfate Revenue (2020-2025) & (US$ Million)
Figure 89. Amikacin Sulfate Industry Chain Mapping
Figure 90. Regional Amikacin Sulfate Manufacturing Base Distribution (%)
Figure 91. Amikacin Sulfate Production Process
Figure 92. Regional Amikacin Sulfate Production Cost Structure
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Amikacin Sulfate market?
The top companies in the global Amikacin Sulfate market are Chengdu Brilliant Pharmaceutical Group、Chongqing Daxin Pharmaceutical、Interquim Mexico.
Related Reports
Amikacin Sulfate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-09
Pages: 135
USD 3950.00
(Single User License)
Global Amikacin Sulfate Market Research Report 2026
The global Amikacin Sulfate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-25
Pages: 131
USD 2900.00
(Single User License)
Global Amikacin Sulfate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Amikacin Sulfate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 79
USD 4250.00
(Single User License)
Global Amikacin Sulfate Market Research Report 2025
The global market for Amikacin Sulfate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-21
Pages: 91
USD 2900.00
(Single User License)
Amikacin Sulfate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-21
Pages: 101
USD 3950.00
(Single User License)
Global Amikacin Sulfate Market Insights, Forecast to 2030
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published Date: 2024-04-16
Pages: 114
USD 4900.00
(Single User License)
Amikacin Sulfate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published Date: 2024-01-25
Pages: 117
USD 3950.00
(Single User License)
Global Amikacin Sulfate Market Research Report 2024
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published Date: 2024-01-11
Pages: 95
USD 2900.00
(Single User License)
Amikacin Sulfate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-09
Pages: 135
USD 3950.00 (Single User License)Global Amikacin Sulfate Market Research Report 2026
The global Amikacin Sulfate market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-25
Pages: 131
USD 2900.00 (Single User License)Global Amikacin Sulfate Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Amikacin Sulfate market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 79
USD 4250.00 (Single User License)Global Amikacin Sulfate Market Research Report 2025
The global market for Amikacin Sulfate was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-21
Pages: 91
USD 2900.00 (Single User License)Amikacin Sulfate- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Amikacin Sulfate was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-21
Pages: 101
USD 3950.00 (Single User License)Global Amikacin Sulfate Market Insights, Forecast to 2030
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published: 2024-04-16
Pages: 114
USD 4900.00 (Single User License)Amikacin Sulfate - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published: 2024-01-25
Pages: 117
USD 3950.00 (Single User License)Global Amikacin Sulfate Market Research Report 2024
Amikacin binds to the 30s subunit of the bacterial ribosome, preventing the read of the RNA, thus prevents the synthesis of necessary proteins for its growth and development.CAS number is 39831-55-5, and the molecular formula is c22h43n5o13.2 (H2SO4).
Published: 2024-01-11
Pages: 95
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now